Anti-cholesterol drugs may do more harm than good for older people

June 3, 2013 by Sunanda Creagh, The Conversation
Elderly people, who often take a lot of different pills, may be at greater risk of side effects caused by statins interacting with other drugs. Credit: http://www.flickr.com/photos/nirbhao/

The side effects of Australia's most commonly prescribed cholesterol-lowering drugs may outweigh the benefits in older people, a new clinical review has found.

More than 40% of Australians over 65 take cholesterol-lowering drugs called statins, which include atorvastatin (marketed as Lipitor), simvastatin (marketed as Zocor) and (marketed as Crestor).

Common side effects from statins include abdominal pain, nausea, and/or weakness and .

University of Sydney and Royal North Shore Hospital researchers Associate Professor Sarah Hilmer and Dr Danijela Gnjidic reviewed randomised trials that included older people, as well as published .

They found that the benefits of statins were unclear in older people who had never experienced heart attack or stroke, while the adverse effects may be more common and have greater impact in older people.

"If you have already had a heart attack, there is good evidence that statins can reduce risk of an early death even in the very old. But if you haven't had a heart attack before, then we don't have evidence that statins help older people," Dr Hilmer said.

"Almost everyone would know someone who has had an adverse effect from a statin. Up to 10% of people in clinical trials get some sort of muscle pain, and if you are an older person without much reserve, that may stop you from walking and functioning independently."

Dr Hilmer said there were also concerns about the association between statins and increased risk of diabetes and .

"One trial looked at people with Alzheimer's and found that those who stopped taking statins had an improvement in their cognitive function," she said.

Patients with severe physical or cognitive impairments, or those in their last year of life, may want to consider reducing statin use, the authors said.

People with , , myalgia (muscle pain) or those who take other drugs that interact with statins may consider discussing withdrawal of statins with their doctor, the researchers said.

People with more severe adverse effects such as rhabdomyolysis (skeletal muscle breakdown) should discuss immediate withdrawal of with their doctor.

Benefit-risk ratio

Dr Ken Harvey, Adjunct Associate Professor at LaTrobe University's School of Public Health welcomed the study.

"It's always useful to remind practitioners that the benefit-risk ratio of pharmacological interventions should be regularly reviewed, especially in the elderly where poly-pharmacy and drug interactions are more common," said Dr Harvey, who was not involved in the study.

"It's important to consider the possibility of adverse drug reactions (and report those suspected), especially in the elderly, because clinical trial experience in this age group is limited."

Dr Harvey said reports of adverse drug reactions can be sent to the Therapeutic Goods Administration, which produces a searchable Database of Adverse Event Notifications.

"Important non-drug advice, such as encouraging people to stop smoking, eat a nutritious diet, moderate their alcohol composition, keep active and maintain an appropriate body weight should always be promoted, regardless of age," he said.

Explore further: Study examines the role adverse reactions play in statin discontinuation

Related Stories

Study examines the role adverse reactions play in statin discontinuation

April 1, 2013
Despite their well-documented benefits, statins, drugs used to lower cholesterol, are commonly discontinued in routine care. Statin discontinuation has been linked to increased risk for cardiovascular events and death in ...

Cholesterol-lowering drug may reduce exercise benefits for obese adults, study finds

May 15, 2013
Statins, the most widely prescribed drugs worldwide, are often suggested to lower cholesterol and prevent heart disease in individuals with obesity, diabetes and metabolic syndrome, which is a combination of medical disorders ...

Statin use is linked to increased risk of developing diabetes, warn researchers

May 23, 2013
Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a paper published today in BMJ.

Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins

March 11, 2013
Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt ...

Potency of statins linked to muscle side effects

August 22, 2012
A study from the University of California, San Diego School of Medicine, published August 22 online by PLoS ONE, reports that muscle problems reported by patients taking statins were related to the strength or potency of ...

High potency statins pose significantly higher risk of kidney injury than low potency, say experts

March 19, 2013
Patients taking high potency statins for high blood pressure are at a 34% higher risk of being hospitalised for acute kidney injury (AKI), compared with those taking low potency statins, a paper published today in BMJ suggests.

Recommended for you

Mouse studies shed light on how protein controls heart failure

October 18, 2017
A new study on two specially bred strains of mice has illuminated how abnormal addition of the chemical phosphate to a specific heart muscle protein may sabotage the way the protein behaves in a cell, and may damage the way ...

Newborns with trisomy 13 or 18 benefit from heart surgery, study finds

October 18, 2017
Heart surgery significantly decreases in-hospital mortality among infants with either of two genetic disorders that cause severe physical and intellectual disabilities, according to a new study by a researcher at the Stanford ...

Saving hearts after heart attacks: Overexpression of a gene enhances repair of dead muscle

October 17, 2017
University of Alabama at Birmingham biomedical engineers report a significant advance in efforts to repair a damaged heart after a heart attack, using grafted heart-muscle cells to create a repair patch. The key was overexpressing ...

High blood pressure linked to common heart valve disorder

October 17, 2017
For the first time, a strong link has been established between high blood pressure and the most common heart valve disorder in high-income countries, by new research from The George Institute for Global Health at the University ...

Blood cancer gene could be key to preventing heart failure

October 16, 2017
A new study, published today in Circulation, shows that the gene Runx1 increases in damaged heart muscle after a heart attack. An international collaboration led by researchers from the University of Glasgow, found that mice ...

Mitochondrial DNA could predict risk for sudden cardiac death, heart disease

October 11, 2017
Johns Hopkins researchers report that the level, or "copy number," of mitochondrial DNA—genetic information stored not in a cell's nucleus but in the body's energy-creating mitochondria—is a novel and distinct biomarker ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.